Method for treating a mucus secretion
View Patent ↗A method and composition for treating a patient suffering from an excessive mucus secretion includes administration to the patient of a therapeutically effective amount of a botulinum toxin type A, B, C, D, E, F and/or G.
1. A method for treating a mucus secretion of a patient, the method comprising the step of administering an effective amount of a botulinum toxin to a region of a patient selected from the group consisting of the gastrointestinal tract and the genital tract in order to reduce a mucus secretion of the patient, wherein the mucus secretion is not a symptom of rhinorrhea.
2. The method of claim 1 , wherein the mucus secretion is a cholinergic influenced mucus secretion.
3. The method of claim 1 , wherein the botulinum toxin is botulinum toxin type A.
4. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
5. The method of claim 1 , wherein the botulinum toxin is administered in an amount of between 0.01 units and 5000 units.
6. The method of claim 1 , wherein the botulinum toxin is administered in an amount of between 0.01 unit and 500 units.
7. A method for treating a cholinergic influenced mucus secretion of a human patient, the method comprising the step of administering a therapeutically effective amount of botulinum toxin type A to a region of a patient selected from the group consisting of the gastrointestinal tract and the genital tract in order to reduce the mucus secretion, wherein the mucus secretion is not a symptom of rhinorrhea.
8. A method for treating a mucus secreting gland, the method comprising the step of administering to a mucus secreting gland of a region selected from the group consisting of the gastrointestinal tract, the genital tract, and the respiratory tract of a patient a botulinum toxin thereby reducing a mucus secretory activity of the gland, wherein the mucus secretion is not a symptom of rhinorrhea.
9. The method of claim 8 , wherein the gland is an excessively secreting mucus gland.
10. The method of claim 8 , wherein the mucus gland is influenced by the cholinergic nervous system.
11. The method of claim 8 , wherein the botulinum toxin is administered by injection into the mucus gland or into the local area of the mucus gland.
12. The method of claim 8 , wherein the botulinum toxin is botulinum toxin type A.
13. The method of claim 8 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.
14. The method of claim 8 , wherein the botulinum toxin is administered in an amount of between 0.01 units and 5000 units.
15. The method of claim 8 , wherein the botulinum toxin is administered in an amount of between 0.01 units and 500 units.
16. A method for treating an excessively secreting mucus gland, the method comprising the step of injecting an excessively secreting, cholinergic nervous system influenced mucus gland or local mucus gland area of a region selected from the group consisting of the gastrointestinal tract, the genital tract, and the respiratory tract of a human patient with a therapeutically effective amount of botulinum toxin type A in order to reduce the excessive mucus gland secretion, wherein the mucus secretion is not a symptom of rhinorrhea.
17. The method of claim 1 , wherein the botulinum toxin is administered into a hyperactive intestinal mucosa.